Cart
sales@molnova.com
BCP-T.A
CAS No. 2786829-70-5
BCP-T.A( —— )
Catalog No. M35673 CAS No. 2786829-70-5
BCP-T.A is an ferroptosis inducer that acts by binding to GPX4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 135 | In Stock |
|
| 10MG | 198 | In Stock |
|
| 25MG | 338 | In Stock |
|
| 50MG | 490 | In Stock |
|
| 100MG | 697 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBCP-T.A
-
NoteResearch use only, not for human use.
-
Brief DescriptionBCP-T.A is an ferroptosis inducer that acts by binding to GPX4.
-
DescriptionBCP-T.A, a tunable heterocyclic electrophile, is a potent ferroptosis inducer by binding to GPX4. BCP-T.A is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
-
In VitroBCP-T.A induces ferroptosis in various cell lines (NCI-H522, T-1080, MDA-MB-468, MDA-MB-231, HeLa, HCT-116, U2OS, WI-38, and MEFS) with IC50 values of 10 nM-367 nM.BCP-T.A (0.5 μM, 3 h) binds to GPX4 and increases lipid peroxides, indicated by cellular thermal shift assay (CETSA).
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetFerroptosis
-
RecptorFerroptosis | GPX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2786829-70-5
-
Formula Weight456.39
-
Molecular FormulaC23H19Cl2N3OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C=1N=C(C#C)SC1)N2CCN(CC2)C(C3=CC=C(Cl)C=C3)C4=CC=C(Cl)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Endri Karaj, et al. Design, Synthesis, and Monoamine Oxidase B Selective Inhibitory Activity of N-Arylated Heliamine Analogues. J Med Chem. 2022 Aug 19. ?
molnova catalog
related products
-
Vamifeport
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.
-
SRS16-86
SRS16-86 is a novel third-generation ferrostatin, is an inhibitor of?ferroptosis.
-
Cerivastatin sodium
Cerivastatin sodium (BAY W 6228 sodium) is an orally active and highly potent HMG-CoA reductase inhibitor with lipid-lowering activity that can reduce low-density lipoprotein cholesterol levels.
